59722-33-7

Usage

Uses

Used in Coatings and Inks Industry:
4-HYDROXYPHENYL METHANESULFONATE is used as a photoinitiator for the production of ultraviolet-curable inks and coatings. It aids in the curing process by initiating the polymerization reaction upon exposure to UV light, enhancing the efficiency and performance of the final product.
Used in Polymer and Resin Production:
In the polymer and resin industry, 4-HYDROXYPHENYL METHANESULFONATE is used as a cross-linking agent. It helps in forming a network structure within the polymers and resins, improving their mechanical properties and thermal stability.
Used in Pharmaceutical Industry:
4-HYDROXYPHENYL METHANESULFONATE has been studied for its potential use in pharmaceuticals. Its properties are being explored for possible applications in drug development and formulation, although further research is needed to fully understand its capabilities in this field.
Used as an Antioxidant:
4-HYDROXYPHENYL METHANESULFONATE is also considered for its potential antioxidant properties. It may be used in various products to prevent oxidation, which can lead to degradation or spoilage, thus extending the shelf life and maintaining the quality of the products.

InChI:InChI=1/C7H8O4S/c1-12(9,10)11-7-4-2-6(8)3-5-7/h2-5,8H,1H3

Upstream product

• 701285-81-6 4-(methanesulfonyl)oxy-1-(benzyloxy)benzene 
• 124-63-0 methanesulfonyl chloride 
• 123-31-9 hydroquinone 
• 150-78-7 1,4-dimethoxybezene 
• 126150-65-0 dimethanesulfonate hydroquinone 
• 19013-30-0 p-methoxyphenyl mesylate 

Downstream Products

• 1432474-16-2 4-(fluoromethoxy)phenyl methanesulfonate 
• 1432474-15-1 2-(4-((methylsulfonyl)oxy)phenoxy)acetic acid 
• 1435486-13-7 C₁₁H₁₄O₆S 
• 59893-20-8 O-ethyl O-[4-(methanesulfonyloxy)phenyl] S-n-propyl phosphorodithioate 
• 851124-38-4 3-(4-methanesulfonyloxyphenoxy)propylbromide 
• 19013-30-0 p-methoxyphenyl mesylate 

Relevant academic research and scientific papers

NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS

The present invention relates to certain novel compounds of the formula (I) to processes for preparing such compounds, to their the utility in modulation of nuclear hormone receptors Liver X Receptor (LXR) α (NR1H3) and/or β (NR1H2) and in treating and/or preventing clinical conditions including cardiovascular diseases such as atherosclerosis; inflammatory diseases, Alzheimer's disease, lipid disorders (dyslipidemias) whether or not associated with insulin resistance, type 2 diabetes and other manifestations of the metabolic syndrome, to methods for their therapeutic use and to pharmaceutical compositions containing them.

NOVEL COMPOUNDS AND THEIR USE IN MEDICINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

The present invention relates to novel compounds of formula (I) and their pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds.

Selected sulfonyl compounds as anticancer/antimalarial agents

The synthesis and biological testing of a series of sulfonyl phenols and sulfonyl aryl methyl ethers has revealed that p-methoxyphenyl p-toluenesulfonate is a very selective and effective antimalarial agent which shows pronounced activity against human skin cancer cells. Application of a counter-attack strategy permits the direct preparation of the requisite tosylate ether from the bis(tosylate) of dihydroquinone.